Angiotensin II and III metabolism and effects on steroid production in the HAC15 human adrenocortical cell line

Endocrinology

Volumn 154, Issue 1, 2013, Pages 214-221

  Oki, Kenji ^a,b,d   Kopf, Phillip G ^e   Campbell, William B ^e   Lam, Milay Luis ^a,b   Yamazaki, Takeshi ^f   Gomez Sanchez, Celso E ^a,b   Gomez Sanchez, Elise P ^a,b,c  

^a G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d NATIONAL HOSPITAL ORGANIZATION   (Japan)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN III; ANGIOTENSIN[1-7]; CYTOCHROME P450; CYTOCHROME P450 1B1; CYTOCHROME P450 1B2; HYDROCORTISONE; LOSARTAN; MESSENGER RNA; STEROID 17ALPHA MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROIDOGENESIS;

3-HYDROXYSTEROID DEHYDROGENASES; ADRENAL CORTEX; ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN III; CELL LINE; HUMANS; HYDROCORTISONE; LOSARTAN; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE;

EID: 84871708442     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1557     Document Type: Article

References (40)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266-3281
2. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248 (Pubitemid 40523144)
3. Kaschina E, Unger T 2003 Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 12:70 -88
4. Hattangady NG, Olala LO, Bollag WB, Rainey WE 2012 Acute and chronic regulation of aldosterone production. Mol Cell Endocrinol 350:151-162
5. Yang HY, Erdös EG, Levin Y 1971 Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme). J Pharmacol Exp Ther 177:291-300
6. Zini S, Fournie-Zaluski MC, Chauvel E, Roques BP, Corvol P, Llorens-Cortes C 1996 Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 93:11968-11973 (Pubitemid 26347232)
7. Ferrario CM, Iyer SN 1998 Angiotensin-(1-7): a bioactive fragment of the renin-angiotensin system. Regul Pept 78:13-18 (Pubitemid 28561512)
8. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ 2000 A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275:33238-33243
9. Bosnyak S, Jones ES, Christopoulos A, Aguilar MI, Thomas WG, Widdop RE Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci (Lond) 121:297-303
10. Zhuo JL, Li XC 2011 New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides 32:1551-1565
11. Campbell WB, Brooks SN, Pettinger WA 1974 Angiotensin IIand angiotensin 3-induced aldosterone release vivo in the rat. Science 184:994-996
12. Gammelgaard I, Wamberg S, Bie P 2006 Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin- aldosterone-system. Acta Physiol (Oxf) 188:129-138 (Pubitemid 44337810)
13. Yatabe J, Yoneda M, Yatabe MS, Watanabe T, Felder RA, Jose PA, Sanada H 2011 Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor. Endocrinology 152:1582-1588
14. Goodfriend TL, Peach MJ 1975 Angiotensin III: (DES-aspartic acid-1)-angiotensin II. Evidence and speculation for its role as an important agonist in the renin-angiotensin system. Circ Res 36:38-48
15. Wamberg C, Plovsing RR, Sandgaard NC, Bie P 2003 Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs. Am J Physiol Regul Integr Comp Physiol 285:R971-R980 (Pubitemid 37296347)
16. Plovsing RR, Wamberg C, Sandgaard NC, Simonsen JA, Hol-stein-Rathlou NH, Hoilund-Carlsen PF, Bie P 2003 Effects of truncated angiotensins in humans after double blockade of the renin system. Am J Physiol Regul Integr Comp Physiol 285:R981-R991
17. Parmar J, Key RE, Rainey WE 2008 Development of an adreno-corticotropin- responsive human adrenocortical carcinoma cell line. J Clin Endocrinol Metab 93:4542-4546 (Pubitemid 352789558)
18. Wang T, Rainey WE 2012 Human adrenocortical carcinoma cell lines. Mol Cell Endocrinol 351:58 -65
19. Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE 2012 Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology 153:1774-1782
20. Nishimoto K, Rigsby CS, Wang T, Mukai K, Gomez-Sanchez CE, Rainey WE, Seki T 2012 Transcriptome analysis reveals differentially expressed transcripts in rat adrenal zona glomerulosa and zona fasciculata. Endocrinology 153:1755-1763
21. Gomez-Sanchez CE, Foecking MF, Ferris MW, Chavarri MR, Uribe L, Gomez-Sanchez EP 1987 The production of monoclonal antibodies against aldosterone. Steroids 49:581-587
22. Morra di Cella S, Veglio F, Mulatero P, Christensen V, Aycock K, Zhu Z, Gomez-Sanchez EP, Gomez-Sanchez CE 2002 A time-resolved fluoroimmunoassay for 18-oxocortisol and 18-hydroxycortisol. Development of a monoclonal antibody to 18-oxocortisol. J Steroid Biochem Mol Biol 82:83-88 (Pubitemid 35341403)
23. Cui L, Nithipatikom K, Campbell WB 2007 Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS/MS: metabolism by bovine adrenal endothelial cells. Anal Biochem 369:27-33 (Pubitemid 47313381)
24. Gauthier KM, Zhang DX, Cui L, Nithipatikom K, Campbell WB 2008 Angiotensin II relaxations of bovine adrenal cortical arteries: role of angiotensin II metabolites and endothelial nitric oxide. Hypertension 52:150-155
25. Balla T, Baukal AJ, Eng S, Catt KJ 1991 Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla. Mol Pharmacol 40:401-406
26. Aguilera G 1992 Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat. Mol Cell Endocrinol 90:53-60
27. Hajnóczky G, Csordás G, Bagó A, Chiu AT, Spät A 1992 Angiotensin II exerts its effect on aldosterone production and potassium permeability through receptor subtype AT1 in rat adrenal glomerulosa cells. Biochem Pharmacol 43:1009-1012
28. Spät A, Hunyady L 2004 Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84:489-539 (Pubitemid 38365491)
29. Hunyady L, Catt KJ 2006 Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 20:953-970
30. Li Q, Zhang L, Pfaffendorf M, van Zwieten PA 1995 Comparative effects of angiotensin II and its degradation products angiotensin III and angiotensin IV in rat aorta. Br J Pharmacol 116:2963-2970
31. Li Q, Feenstra M, Pfaffendorf M, Eijsman L, van Zwieten PA 1997 Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein. J Cardiovasc Pharmacol 29:451-456 (Pubitemid 27212747)
32. Robertson MJ, Cunoosamy MP, Clark KL 1992 Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta. Br J Pharmacol 106:166-172
33. Wright JW, Harding JW 1995 Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions. Regul Pept 59:269-295
34. Bird IM, Mason JI, Rainey WE 1994 Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. Endocrinology 134:2468-2474 (Pubitemid 24170859)
35. Reaux A, Fournie-Zaluski MC, David C, Zini S, Roques BP, Corvol P, Llorens-Cortes C 1999 Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci USA 96:13415-13420
36. Benter IF, Yousif MH, Cojocel C, Al-Maghrebi M, Diz DI 2007 Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction. Am J Physiol Heart Circ Physiol 292:H666-H672 (Pubitemid 46105230)
37. Grobe JL, Mecca AP, Mao H, Katovich MJ 2006 Chronic an-giotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol 290:H2417-H2423 (Pubitemid 43846070)
38. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T 2003 Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100:8258 -8263
39. Hanke CJ, Holmes BB, Xu Y, Nithipatikom K, Campbell WB 2007 Endothelium-derived steroidogenic factor enhances angiotensin II-stimulated aldosterone release by bovine zona glomerulosa cells. Endocrinology 148:317-323 (Pubitemid 46021464)
40. Nishimoto K, Nakagawa K, Li D, Kosaka T, Oya M, Mikami S, Shibata H, Itoh H, Mitani F, Yamazaki T, Ogishima T, Suematsu M, Mukai K 2010 Adrenocortical zonation in humans under normal and pathological conditions. J Clin Endocrinol Metab 95:2296-2305